Moderna (MRNA) IV into COVID-19 vaccine boosters get FDA authorization

Moderna (NASDAQ: MRNA) 30-day option implied volatility is at 60; compared to its 52-week range of 51 to 131 into MRNA & Johnson & Johnson (JNJ) COVID-19 vaccine boosters get FDA authorization.

You May Also Be Interested In

• Boeing (BA) call put ratio 1.4 calls to 1 put as share price down 5.6%
• GE Vernova (GEV) call put ratio 1 call to 1 put as share price up 5.7%
• Mattel (MAT) call put ratio 46 calls to 1 put with a focus on January 12, January 13 and March 13 calls as share price down 1.3%